Aptevo Therapeutics Statistics

Total Valuation

APVO has a market cap or net worth of $5.06 million. The enterprise value is $1.74 million.

Market Cap	5.06M
Enterprise Value	1.74M

Important Dates

The next estimated earnings date is Tuesday, March 4, 2025, before market open.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

APVO has 1.46 million shares outstanding.

Current Share Class	1.46M
Shares Outstanding	1.46M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+186.34%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	4.85%
Float	1.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.06
P/TBV Ratio	1.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.72, with a Debt / Equity ratio of 1.14.

Current Ratio	1.72
Quick Ratio	1.40
Debt / Equity	1.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -284.28% and return on invested capital (ROIC) is -110.74%.

Return on Equity (ROE)	-284.28%
Return on Assets (ROA)	-76.06%
Return on Invested Capital (ROIC)	-110.74%
Return on Capital Employed (ROCE)	-262.17%
Revenue Per Employee	n/a
Profits Per Employee	-$603,250
Employee Count	40
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -98.52% in the last 52 weeks. The beta is 5.09, so APVO's price volatility has been higher than the market average.

Beta (5Y)	5.09
52-Week Price Change	-98.52%
50-Day Moving Average	4.66
200-Day Moving Average	12.65
Relative Strength Index (RSI)	33.43
Average Volume (20 Days)	43,958

Short Selling Information

The latest short interest is 43,656, so 2.99% of the outstanding shares have been sold short.

Short Interest	43,656
Short Previous Month	26,511
Short % of Shares Out	2.99%
Short % of Float	2.99%
Short Ratio (days to cover)	0.67

Income Statement

Revenue	n/a
Gross Profit	-302,000
Operating Income	-24.60M
Pretax Income	-24.95M
Net Income	-24.13M
EBITDA	-24.25M
EBIT	-24.60M
Earnings Per Share (EPS)	-$87.38

Full Income Statement

Balance Sheet

The company has $8.71 million in cash and $5.40 million in debt, giving a net cash position of $3.32 million or $2.27 per share.

Cash & Cash Equivalents	8.71M
Total Debt	5.40M
Net Cash	3.32M
Net Cash Per Share	$2.27
Equity (Book Value)	4.76M
Book Value Per Share	3.26
Working Capital	4.45M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-23.79M
Capital Expenditures	n/a
Free Cash Flow	-23.79M
FCF Per Share	-$16.31

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APVO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-476.80%
FCF Yield	-469.98%

Analyst Forecast

The average price target for APVO is $296.00, which is 8,430.26% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$296.00
Price Target Difference	8,430.26%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 4, 2024. It was a reverse split with a ratio of 0.027027:1.

Last Split Date	Dec 4, 2024
Split Type	Reverse
Split Ratio	0.027027:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1